Cartesian Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Cartesian Therapeutics, Inc. (RNAC) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-03-09
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$5.85M, a 211.28% decline from fiscal 2023.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $5.26M.
- Cartesian Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$64.71M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | -$412.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | -$412.00K derived: sum of 3 quarters · filed 2026-03-09 | -$5.85M 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$412.00K derived: sum of 2 quarters · filed 2025-11-06 | -$5.85M 10-Q · filed 2025-11-06 | -$8.12M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$5.85M 10-Q · filed 2025-08-07 | -$8.12M derived: sum of 3 quarters · filed 2025-08-07 | -$9.10M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$5.44M 10-Q · filed 2025-05-08 | -$7.71M derived: sum of 2 quarters · filed 2025-05-08 | -$8.69M derived: sum of 3 quarters · filed 2025-05-08 | -$9.34M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$3.25M derived: sum of 2 quarters · filed 2025-03-13 | -$3.90M derived: sum of 3 quarters · filed 2025-03-13 | $5.26M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$976.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.63M derived: sum of 2 quarters · filed 2024-11-07 | $7.53M 10-Q · filed 2024-11-07 | -$1.14M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$654.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.50M 10-Q · filed 2024-08-08 | -$159.00K derived: sum of 3 quarters · filed 2024-08-08 | -$13.99M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $9.16M 10-Q · filed 2024-05-08 | $495.00K derived: sum of 2 quarters · filed 2024-05-08 | -$13.34M derived: sum of 3 quarters · filed 2024-05-08 | -$28.66M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$22.49M derived: sum of 2 quarters · filed 2024-03-07 | -$37.82M derived: sum of 3 quarters · filed 2024-03-07 | -$64.71M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$13.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$29.15M derived: sum of 2 quarters · filed 2023-11-13 | -$56.04M 10-Q · filed 2023-11-13 | -$73.12M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | -$15.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | -$42.21M 10-Q · filed 2023-08-17 | -$59.28M derived: sum of 3 quarters · filed 2024-03-07 | -$76.66M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$26.89M 10-Q · filed 2023-05-04 | -$43.96M derived: sum of 2 quarters · filed 2024-03-07 | -$61.34M derived: sum of 3 quarters · filed 2024-03-07 | -$69.66M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$17.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$34.45M derived: sum of 2 quarters · filed 2024-03-07 | -$42.77M derived: sum of 3 quarters · filed 2024-03-07 | -$45.50M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$17.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$25.70M derived: sum of 2 quarters · filed 2022-11-03 | -$28.42M 10-Q · filed 2022-11-03 | -$33.47M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$11.05M 10-Q · filed 2022-08-08 | -$16.10M derived: sum of 3 quarters · filed 2023-03-02 | $81.42M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$2.73M 10-Q · filed 2022-05-05 | -$7.78M derived: sum of 2 quarters · filed 2023-03-02 | $89.73M derived: sum of 3 quarters · filed 2023-03-02 | $91.73M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $92.46M derived: sum of 2 quarters · filed 2023-03-02 | $94.46M derived: sum of 3 quarters · filed 2023-03-02 | $94.46M 10-K · filed 2023-03-02 |
| 2020-09-30 | $97.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $99.51M derived: sum of 2 quarters · filed 2021-11-09 | $99.51M 10-Q · filed 2021-11-09 | $99.86M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.00M 10-Q · filed 2021-08-12 | $2.35M derived: sum of 3 quarters · filed 2022-03-10 | $2.35M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | $350.00K derived: sum of 2 quarters · filed 2022-03-10 | $348.00K derived: sum of 3 quarters · filed 2022-03-10 | $339.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $348.00K derived: sum of 2 quarters · filed 2022-03-10 | $339.00K derived: sum of 3 quarters · filed 2022-03-10 | $337.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$11.00K derived: sum of 2 quarters · filed 2020-11-05 | -$13.00K 10-Q · filed 2020-11-05 | -$924.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$11.00K 10-Q · filed 2020-08-06 | -$922.00K derived: sum of 3 quarters · filed 2021-03-12 | -$24.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$2.00K 10-Q · filed 2020-05-07 | -$913.00K derived: sum of 2 quarters · filed 2021-03-12 | -$15.00K derived: sum of 3 quarters · filed 2021-03-12 | -$103.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | -$911.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$13.00K derived: sum of 2 quarters · filed 2021-03-12 | -$101.00K derived: sum of 3 quarters · filed 2021-03-12 | -$101.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | $898.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $810.00K derived: sum of 2 quarters · filed 2019-11-08 | $810.00K 10-Q · filed 2019-11-08 | $3.31M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$88.00K 10-Q · filed 2019-08-08 | $2.41M derived: sum of 3 quarters · filed 2020-03-12 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $2.50M derived: sum of 2 quarters · filed 2020-03-12 | ||
| 2017-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.43M 10-K · filed 2020-03-12 | ||
| 2017-09-30 | -$66.00K 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $10.41M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |